Navigation Links
HeartWare to Report Financial Results for Third Quarter of 2010
Date:10/20/2010

FRAMINGHAM, Mass. and SYDNEY, Oct. 20 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX:HIN) will release financial results for the third quarter and nine months ended September 30, 2010 prior to the open of the U.S. stock markets on Wednesday, November 3, 2010.

A conference call with management is scheduled for 8:00 am U.S. Eastern Daylight Time on Wednesday, November 3, 2010 (11:00 pm Australian Eastern Daylight Time on Wednesday, November 3, 2010) to discuss the Company's financial results, quarterly highlights and business outlook.  The call may be accessed by dialing 1-877-407-4018 five minutes prior to the scheduled start time and referencing "HeartWare."  For callers outside the United States, please dial + 1-201-689-8471.

A live webcast of the call will also be available at the Company's website (www.heartware.com) by selecting "HeartWare Third Quarter Conference Call" under the section titled "Corporate Presentations" on the Home Page.  A replay of the conference call will be available through the above weblink immediately following completion of the call.

A copy of the news release announcing results and related information will be available on the Company's web site, www.heartware.com.

About HeartWare InternationalHeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure.  The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.  HeartWare has received CE Marking for the HeartWare System in the European Union.  The device is currently the subject of United States clinical trials for two indications: destination therapy and bridge-to-transplant under a continued access protocol.  For additional information, please visit the company's website at www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000® and its securities are publicly traded on The NASDAQ Stock Market and the Australian Securities Exchange.For further information:Christopher TaylorHeartWare International, Inc.Email: ctaylor@heartwareinc.comPhone: +1 508 739 0864
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Presentation of HeartWare Clinical Results
2. HeartWare International Clinical Trial Shows 90% Survival at 180 Days
3. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
4. HeartWare International Reports Third Quarter Revenues of $7.5 Million
5. HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City
6. HeartWare to Present at the UBS 2010 Global Life Sciences Conference
7. HeartWare to Present at Lazard Capital Markets Circulatory Assist Device Day
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Spherix Reports Second Quarter Earnings
10. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
11. Tapestry Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... 2017 Results show Gamma Knife spares normal ... radiotherapy platforms Elekta (EKTA-B.ST) today announced new ... and delivers a higher radiation dose compared to linear accelerator ... large or complex brain tumors, were published in the ... ...
(Date:1/24/2017)... 24, 2017 www.Financialbuzz.com - ... in the United States as eight ... In addition, Proposition 64, the California Cannabis Legalization Initiative, was ... on November 8, 2016. This outcome means that individuals in ... to grow a certain amount of cannabis for personal use. ...
(Date:1/24/2017)... The global  mammography market  is ... by 2025, according to a new report by Grand ... to the rising initiatives by various governments and NGOs ... in breast tissue. Some significant organizations such as the ... are promoting the early diagnosis of mammary gland calcification, ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... This Saturday, January 28, the BCFA ... very special performance by Alabama Symphony Orchestra musicians Yifan Zhou, Mara McClain & Sarah ... dim sum, and exhibitors offer a look at Chinese games, crafts & more. Festivities ...
(Date:1/24/2017)... ... 24, 2017 , ... The results from the American Cancer Society’s ... for prostate cancer patients: incidents of cancer is down as is the likelihood of ... death rate has dropped from its peak of 215.1 in 1991 to 161.2 in ...
(Date:1/24/2017)... ... January 24, 2017 , ... Today, Taza Agua, ... award-winning bottles, designed specifically to optimize the drinking experience for K-Cup coffee, tea ... for introducing the world’s first untouched bottled water purposed exclusively for creating a ...
(Date:1/24/2017)... ... January 24, 2017 , ... “Choosing Wisdom-Solomon’s Proverbs Reclaimed”: ... leadership, gossip, prostitution, adultery, anger, and common sense. , “Choosing Wisdom-Solomon’s Proverbs ... Dr. David Coats. In September of 1983, they flew to Haiti to focus ...
(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual Balances”: ... of Spiritual Balances” is the creation of published author, Pastor Bernard J. Weathers, pastor ... holds a bachelor degree in religious education and a master degree in theology. , ...
Breaking Medicine News(10 mins):